Shukur HemraSabit

シュクルヘムラサビット | Shukur HemraSabit

Affiliation and department：

Research field (1)： Neurosurgery

Research keywords (5)： pathology , autophagy , ependymoma , invasion , glioblastoma

Research theme for competitive and other funds (3)：

Papers (48)：

Dini Kurnia Ikliptikawati, Nozomi Hirai, Kei Makiyama, Hemragul Sabit, Masashi Kinoshita, Koki Matsumoto, Keesiang Lim, Makiko Meguro-Horike, Shin-ichi Horike, Masaharu Hazawa, et al. Nuclear transport surveillance of p53 by nuclear pores in glioblastoma. Cell Reports. 2023. 112882-112882
Maki Sakaguchi, Riho Nakajima, Toshiya Ichinose, Shingo Tanaka, Ryouken Kimura, Hemragul Sabit, Satoko Nakada, Mitsutoshi Nakada. α-SMA positive vascular mural cells suppress cyst formation in hemangioblastoma. Brain Tumor Pathology. 2023
Sho Tamai, Toshiya Ichinose, Shabierjiang Jiapaer, Nozomi Hirai, Hemragul Sabit, Shingo Tanaka, Masashi Kinoshita, Masahiko Kobayashi, Atsushi Hirao, Mitsutoshi Nakada. Therapeutic potential of pentamidine for glioma-initiating cells and glioma cells through multimodal antitumor effects. Cancer science. 2023. 114. 7. 2920-2930
Yi Wang, Maki Sakaguchi, Hemragul Sabit, Sho Tamai, Toshiya Ichinose, Shingo Tanaka, Masashi Kinoshita, Yasuo Uchida, Sumio Ohtsuki, Mitsutoshi Nakada. COL1A2 inhibition suppresses glioblastoma cell proliferation and invasion. Journal of neurosurgery. 2022. 138. 3. 1-10
Nozomu Oikawa, Masashi Kinoshita, Minako Yamamura, Takehiro Uno, Toshiya Ichinose, Hemragul Sabit, Tomoyuki Hayashi, Dai Inoue, Kenichi Harada, Mitsutoshi Nakada. Non-occlusive mesenteric ischemia during bevacizumab treatment for glioblastoma: a case report. Acta neurochirurgica. 2022. 164. 10. 2767-2771

ｍore...

MISC (5)：

Sho Tamai, Shabierjiang Jiapaer, Guangtao Zhang, Jiakang Zhang, Yi Wang, Hemragul Sabit, Shingo Tanaka, Masashi Kinoshita, Atsushi Hirao, Mitsutoshi Nakada. PENTAMIDINE; A NEW CHEMOTHERAPY TARGETING ON GLIOMA STEM LIKE CELLS. NEURO-ONCOLOGY. 2019. 21. 68-68
Mitsutoshi Nakada, Yu Dong, Tomohiro Kitabayashi, Hemragul Sabit, Takuya Furuta, Atsushi Hirao. DRUG REPOSITIONING TARGETING GLIOMA STEM CELLS. NEURO-ONCOLOGY. 2016. 18. 48-49
Mitsutoshi Nakada, Takuya Furuta, Hemragul Sabit, Yuri Chikano, Yutaka Hayashi, Hiroshi Sato, Toshinari Minamoto, Jun-ichiro Hamada. GLYCOGEN SYNTHASE KINASE 3 beta PROMOTES GLIOMA INVASION VIA THE FAK/Rac1/JNK/MMP2 PATHWAY. NEURO-ONCOLOGY. 2013. 15. 7-7
Mitsutoshi Nakada, Yutaka Hayashi, Katsuyoshi Miyashita, Masashi Kinoshita, Takuya Furuta, Hemragul Sabit, Daisuke Kita, Yasuhiko Hayashi, Naoyuki Uchiyam, Kazuyuki Kawakami, et al. PHASE I/II STUDY FOR RECURRENT GLIOBLASTOMA WITH THE DRUGS INHIBITING GSK3 beta. NEURO-ONCOLOGY. 2012. 14. 77-78
Hemragul Sabit, Takashi Yamazaki, Takeshi Oya, Yoko Ishii, Masakiyo Sasahara. Study about PDGF receptors and their signaling in peripheral nerve regeneration. NEUROSCIENCE RESEARCH. 2006. 55. S116-S116

Lectures and oral presentations (8)：

Immunohistochemical analysis of EphB receptor/ephrin in ependymoma
(The 38th Annual Meeting of the Japan Society of Brain Tumor Pathology 2020)
7.The nucleoporin constituent Tpr is an autophagy induced cell death suppressor in ependymoma
(The 37th Annual Meeting of Japan Society of Brain Tumor Pathology 2019)
Tpr is an autophagy induced cell death suppressor in ependymoma.
(The 36th Annual Meeting of Japan Society of Brain Tumor Pathology 2018)
Tpr-Aurora A kinase signaling pathway in ependymoma
(The 35th Annual Meeting of Japan Society of Brain Tumor Pathology 2017)
The analysis of Tpr in ependymoma
(The 34th Annual Meeting of Japan Society of Brain Tumor Pathology 2016)

ｍore...

Education (1)：

Professional career (1)：

Work history (1)：

Association Membership(s) (2)：

日本分子脳神経外科学会 , THE JAPAN SOCIETY OF BRAIN TUMOR PATHOLOGY

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page